Upgrade to SI Premium - Free Trial

Insys Therapeutics (INSY) Granted FDA Fast Track Designation for Cannabidiol for Prader-Willi Syndrome

December 26, 2017 8:30 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News

Next Articles